Cara Therapeutics Inc (NAS:CARA)
$ 0.304 0.0159 (5.52%) Market Cap: 16.68 Mil Enterprise Value: -21.94 Mil PE Ratio: 0 PB Ratio: 23.38 GF Score: 33/100

Cara Therapeutics Inc Presenting Therapeutics KARE Phase 2 Topline Data -Corporate Call Transcript

Apr 29, 2021 / 12:00PM GMT
Release Date Price: $14.07 (-45.44%)
Operator

Welcome to the Cara KARE Phase II Top Line Data Call. My name is John, and I'll be your operator for today's call. (Operator Instructions)

And I will now turn the call over to Jack Hildick-Smith.

Jack Hildick;Smith
Stern Investor Relations, Inc. - Analyst

Good morning. This is Jack Hildick-Smith with Stern Investor Relations, and welcome to Cara Therapeutics KARE Top Line Data Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Cara's request.

The news release describing the top line data became available at 7:00 a.m. today and can be found on our website at www.caratherapeutics.com. with further details available in a current report on Form 8-K filed with the U.S. Securities and Exchange Commission this morning. A PowerPoint slide deck describing the details of the top line data is posted on the Investors section of the website, and you may listen to a live webcast and replay of today's call on the same

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot